Floor Backes

The Ohio State University Comprehensive Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

David Bender

The University of Iowa University College

UNITED STATES

View details

Martin Hruda

Fakultní Nemocnice Hradec Králové

CZECH REPUBLIC

View details

Roberto Vargas

Assistant Professor

Cleveland Clinic

UNITED STATES

View details

Jonathan Lim

GlaxoSmithKline (United States)

UNITED STATES

View details

BJ Rimel

Division Chief, Gynecologic Oncology

Fred Hutch Cancer Center

UNITED STATES

View details

Casey Cosgrove

Ohio State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Floor Backes

Research Interests

Explore related searches

Contact this professor

Articles (9)

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors

Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer

Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research

Non-surgical management of recurrent Paget’s disease of the vulva: A case report

ENGOT-en11/GOG-3053/KEYNOTE-B21: A Randomised, Double-Blind, Phase 3 Study of Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy in Patients With Newly Diagnosed, High-Risk Endometrial Cancer

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial

NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.

Varying presentations of immune checkpoint inhibitor-associated myocarditis: A case report of the clinical characteristics and outcomes of three patients

Expression of microRNAs and their target genes in melanomas originating from gynecologic sites

Collaborators (6)

David Bender

Martin Hruda

Roberto Vargas

Jonathan Lim

BJ Rimel

Casey Cosgrove

Make your next move.